Pharma & Healthcare
Global ADHD Medications Market Research Report 2024
- Jan 29, 24
- ID: 47748
- Pages: 75
- Figures: 136
- Views: 12
ADHD medications can help reduce symptoms of hyperactivity, inattentiveness, and impulsivity in children and adults with attention deficit hyperactivity disorder (ADHD), formerly known as ADD.
The global ADHD Medications market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for ADHD Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ADHD Medications.
Report Scope
The ADHD Medications market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global ADHD Medications market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the ADHD Medications companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amneal Pharmaceuticals
Eli Lilly and Co.
Johnson and Johnson Services
NEOS Therapeutic
Takeda Pharmaceutical
Pfizer
Lupin
Shire
Mallinckrodt
Segment by Type
Stimulant
Non-stimulant
Segment by Application
Adult
Children
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of ADHD Medications companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global ADHD Medications market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for ADHD Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ADHD Medications.
Report Scope
The ADHD Medications market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global ADHD Medications market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the ADHD Medications companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amneal Pharmaceuticals
Eli Lilly and Co.
Johnson and Johnson Services
NEOS Therapeutic
Takeda Pharmaceutical
Pfizer
Lupin
Shire
Mallinckrodt
Segment by Type
Stimulant
Non-stimulant
Segment by Application
Adult
Children
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of ADHD Medications companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global ADHD Medications Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Stimulant
1.2.3 Non-stimulant
1.3 Market by Application
1.3.1 Global ADHD Medications Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Adult
1.3.3 Children
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global ADHD Medications Market Perspective (2019-2030)
2.2 ADHD Medications Growth Trends by Region
2.2.1 Global ADHD Medications Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 ADHD Medications Historic Market Size by Region (2019-2024)
2.2.3 ADHD Medications Forecasted Market Size by Region (2025-2030)
2.3 ADHD Medications Market Dynamics
2.3.1 ADHD Medications Industry Trends
2.3.2 ADHD Medications Market Drivers
2.3.3 ADHD Medications Market Challenges
2.3.4 ADHD Medications Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top ADHD Medications Players by Revenue
3.1.1 Global Top ADHD Medications Players by Revenue (2019-2024)
3.1.2 Global ADHD Medications Revenue Market Share by Players (2019-2024)
3.2 Global ADHD Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by ADHD Medications Revenue
3.4 Global ADHD Medications Market Concentration Ratio
3.4.1 Global ADHD Medications Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by ADHD Medications Revenue in 2023
3.5 ADHD Medications Key Players Head office and Area Served
3.6 Key Players ADHD Medications Product Solution and Service
3.7 Date of Enter into ADHD Medications Market
3.8 Mergers & Acquisitions, Expansion Plans
4 ADHD Medications Breakdown Data by Type
4.1 Global ADHD Medications Historic Market Size by Type (2019-2024)
4.2 Global ADHD Medications Forecasted Market Size by Type (2025-2030)
5 ADHD Medications Breakdown Data by Application
5.1 Global ADHD Medications Historic Market Size by Application (2019-2024)
5.2 Global ADHD Medications Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America ADHD Medications Market Size (2019-2030)
6.2 North America ADHD Medications Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America ADHD Medications Market Size by Country (2019-2024)
6.4 North America ADHD Medications Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe ADHD Medications Market Size (2019-2030)
7.2 Europe ADHD Medications Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe ADHD Medications Market Size by Country (2019-2024)
7.4 Europe ADHD Medications Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific ADHD Medications Market Size (2019-2030)
8.2 Asia-Pacific ADHD Medications Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific ADHD Medications Market Size by Region (2019-2024)
8.4 Asia-Pacific ADHD Medications Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America ADHD Medications Market Size (2019-2030)
9.2 Latin America ADHD Medications Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America ADHD Medications Market Size by Country (2019-2024)
9.4 Latin America ADHD Medications Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa ADHD Medications Market Size (2019-2030)
10.2 Middle East & Africa ADHD Medications Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa ADHD Medications Market Size by Country (2019-2024)
10.4 Middle East & Africa ADHD Medications Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amneal Pharmaceuticals
11.1.1 Amneal Pharmaceuticals Company Detail
11.1.2 Amneal Pharmaceuticals Business Overview
11.1.3 Amneal Pharmaceuticals ADHD Medications Introduction
11.1.4 Amneal Pharmaceuticals Revenue in ADHD Medications Business (2019-2024)
11.1.5 Amneal Pharmaceuticals Recent Development
11.2 Eli Lilly and Co.
11.2.1 Eli Lilly and Co. Company Detail
11.2.2 Eli Lilly and Co. Business Overview
11.2.3 Eli Lilly and Co. ADHD Medications Introduction
11.2.4 Eli Lilly and Co. Revenue in ADHD Medications Business (2019-2024)
11.2.5 Eli Lilly and Co. Recent Development
11.3 Johnson and Johnson Services
11.3.1 Johnson and Johnson Services Company Detail
11.3.2 Johnson and Johnson Services Business Overview
11.3.3 Johnson and Johnson Services ADHD Medications Introduction
11.3.4 Johnson and Johnson Services Revenue in ADHD Medications Business (2019-2024)
11.3.5 Johnson and Johnson Services Recent Development
11.4 NEOS Therapeutic
11.4.1 NEOS Therapeutic Company Detail
11.4.2 NEOS Therapeutic Business Overview
11.4.3 NEOS Therapeutic ADHD Medications Introduction
11.4.4 NEOS Therapeutic Revenue in ADHD Medications Business (2019-2024)
11.4.5 NEOS Therapeutic Recent Development
11.5 Takeda Pharmaceutical
11.5.1 Takeda Pharmaceutical Company Detail
11.5.2 Takeda Pharmaceutical Business Overview
11.5.3 Takeda Pharmaceutical ADHD Medications Introduction
11.5.4 Takeda Pharmaceutical Revenue in ADHD Medications Business (2019-2024)
11.5.5 Takeda Pharmaceutical Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Detail
11.6.2 Pfizer Business Overview
11.6.3 Pfizer ADHD Medications Introduction
11.6.4 Pfizer Revenue in ADHD Medications Business (2019-2024)
11.6.5 Pfizer Recent Development
11.7 Lupin
11.7.1 Lupin Company Detail
11.7.2 Lupin Business Overview
11.7.3 Lupin ADHD Medications Introduction
11.7.4 Lupin Revenue in ADHD Medications Business (2019-2024)
11.7.5 Lupin Recent Development
11.8 Shire
11.8.1 Shire Company Detail
11.8.2 Shire Business Overview
11.8.3 Shire ADHD Medications Introduction
11.8.4 Shire Revenue in ADHD Medications Business (2019-2024)
11.8.5 Shire Recent Development
11.9 Mallinckrodt
11.9.1 Mallinckrodt Company Detail
11.9.2 Mallinckrodt Business Overview
11.9.3 Mallinckrodt ADHD Medications Introduction
11.9.4 Mallinckrodt Revenue in ADHD Medications Business (2019-2024)
11.9.5 Mallinckrodt Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global ADHD Medications Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Stimulant
1.2.3 Non-stimulant
1.3 Market by Application
1.3.1 Global ADHD Medications Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Adult
1.3.3 Children
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global ADHD Medications Market Perspective (2019-2030)
2.2 ADHD Medications Growth Trends by Region
2.2.1 Global ADHD Medications Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 ADHD Medications Historic Market Size by Region (2019-2024)
2.2.3 ADHD Medications Forecasted Market Size by Region (2025-2030)
2.3 ADHD Medications Market Dynamics
2.3.1 ADHD Medications Industry Trends
2.3.2 ADHD Medications Market Drivers
2.3.3 ADHD Medications Market Challenges
2.3.4 ADHD Medications Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top ADHD Medications Players by Revenue
3.1.1 Global Top ADHD Medications Players by Revenue (2019-2024)
3.1.2 Global ADHD Medications Revenue Market Share by Players (2019-2024)
3.2 Global ADHD Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by ADHD Medications Revenue
3.4 Global ADHD Medications Market Concentration Ratio
3.4.1 Global ADHD Medications Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by ADHD Medications Revenue in 2023
3.5 ADHD Medications Key Players Head office and Area Served
3.6 Key Players ADHD Medications Product Solution and Service
3.7 Date of Enter into ADHD Medications Market
3.8 Mergers & Acquisitions, Expansion Plans
4 ADHD Medications Breakdown Data by Type
4.1 Global ADHD Medications Historic Market Size by Type (2019-2024)
4.2 Global ADHD Medications Forecasted Market Size by Type (2025-2030)
5 ADHD Medications Breakdown Data by Application
5.1 Global ADHD Medications Historic Market Size by Application (2019-2024)
5.2 Global ADHD Medications Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America ADHD Medications Market Size (2019-2030)
6.2 North America ADHD Medications Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America ADHD Medications Market Size by Country (2019-2024)
6.4 North America ADHD Medications Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe ADHD Medications Market Size (2019-2030)
7.2 Europe ADHD Medications Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe ADHD Medications Market Size by Country (2019-2024)
7.4 Europe ADHD Medications Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific ADHD Medications Market Size (2019-2030)
8.2 Asia-Pacific ADHD Medications Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific ADHD Medications Market Size by Region (2019-2024)
8.4 Asia-Pacific ADHD Medications Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America ADHD Medications Market Size (2019-2030)
9.2 Latin America ADHD Medications Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America ADHD Medications Market Size by Country (2019-2024)
9.4 Latin America ADHD Medications Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa ADHD Medications Market Size (2019-2030)
10.2 Middle East & Africa ADHD Medications Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa ADHD Medications Market Size by Country (2019-2024)
10.4 Middle East & Africa ADHD Medications Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amneal Pharmaceuticals
11.1.1 Amneal Pharmaceuticals Company Detail
11.1.2 Amneal Pharmaceuticals Business Overview
11.1.3 Amneal Pharmaceuticals ADHD Medications Introduction
11.1.4 Amneal Pharmaceuticals Revenue in ADHD Medications Business (2019-2024)
11.1.5 Amneal Pharmaceuticals Recent Development
11.2 Eli Lilly and Co.
11.2.1 Eli Lilly and Co. Company Detail
11.2.2 Eli Lilly and Co. Business Overview
11.2.3 Eli Lilly and Co. ADHD Medications Introduction
11.2.4 Eli Lilly and Co. Revenue in ADHD Medications Business (2019-2024)
11.2.5 Eli Lilly and Co. Recent Development
11.3 Johnson and Johnson Services
11.3.1 Johnson and Johnson Services Company Detail
11.3.2 Johnson and Johnson Services Business Overview
11.3.3 Johnson and Johnson Services ADHD Medications Introduction
11.3.4 Johnson and Johnson Services Revenue in ADHD Medications Business (2019-2024)
11.3.5 Johnson and Johnson Services Recent Development
11.4 NEOS Therapeutic
11.4.1 NEOS Therapeutic Company Detail
11.4.2 NEOS Therapeutic Business Overview
11.4.3 NEOS Therapeutic ADHD Medications Introduction
11.4.4 NEOS Therapeutic Revenue in ADHD Medications Business (2019-2024)
11.4.5 NEOS Therapeutic Recent Development
11.5 Takeda Pharmaceutical
11.5.1 Takeda Pharmaceutical Company Detail
11.5.2 Takeda Pharmaceutical Business Overview
11.5.3 Takeda Pharmaceutical ADHD Medications Introduction
11.5.4 Takeda Pharmaceutical Revenue in ADHD Medications Business (2019-2024)
11.5.5 Takeda Pharmaceutical Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Detail
11.6.2 Pfizer Business Overview
11.6.3 Pfizer ADHD Medications Introduction
11.6.4 Pfizer Revenue in ADHD Medications Business (2019-2024)
11.6.5 Pfizer Recent Development
11.7 Lupin
11.7.1 Lupin Company Detail
11.7.2 Lupin Business Overview
11.7.3 Lupin ADHD Medications Introduction
11.7.4 Lupin Revenue in ADHD Medications Business (2019-2024)
11.7.5 Lupin Recent Development
11.8 Shire
11.8.1 Shire Company Detail
11.8.2 Shire Business Overview
11.8.3 Shire ADHD Medications Introduction
11.8.4 Shire Revenue in ADHD Medications Business (2019-2024)
11.8.5 Shire Recent Development
11.9 Mallinckrodt
11.9.1 Mallinckrodt Company Detail
11.9.2 Mallinckrodt Business Overview
11.9.3 Mallinckrodt ADHD Medications Introduction
11.9.4 Mallinckrodt Revenue in ADHD Medications Business (2019-2024)
11.9.5 Mallinckrodt Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global ADHD Medications Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Stimulant
Table 3. Key Players of Non-stimulant
Table 4. Global ADHD Medications Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global ADHD Medications Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global ADHD Medications Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global ADHD Medications Market Share by Region (2019-2024)
Table 8. Global ADHD Medications Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global ADHD Medications Market Share by Region (2025-2030)
Table 10. ADHD Medications Market Trends
Table 11. ADHD Medications Market Drivers
Table 12. ADHD Medications Market Challenges
Table 13. ADHD Medications Market Restraints
Table 14. Global ADHD Medications Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global ADHD Medications Market Share by Players (2019-2024)
Table 16. Global Top ADHD Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ADHD Medications as of 2023)
Table 17. Ranking of Global Top ADHD Medications Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by ADHD Medications Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players ADHD Medications Product Solution and Service
Table 21. Date of Enter into ADHD Medications Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global ADHD Medications Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global ADHD Medications Revenue Market Share by Type (2019-2024)
Table 25. Global ADHD Medications Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global ADHD Medications Revenue Market Share by Type (2025-2030)
Table 27. Global ADHD Medications Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global ADHD Medications Revenue Market Share by Application (2019-2024)
Table 29. Global ADHD Medications Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global ADHD Medications Revenue Market Share by Application (2025-2030)
Table 31. North America ADHD Medications Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America ADHD Medications Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America ADHD Medications Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe ADHD Medications Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe ADHD Medications Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe ADHD Medications Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific ADHD Medications Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific ADHD Medications Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific ADHD Medications Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America ADHD Medications Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America ADHD Medications Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America ADHD Medications Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa ADHD Medications Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa ADHD Medications Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa ADHD Medications Market Size by Country (2025-2030) & (US$ Million)
Table 46. Amneal Pharmaceuticals Company Detail
Table 47. Amneal Pharmaceuticals Business Overview
Table 48. Amneal Pharmaceuticals ADHD Medications Product
Table 49. Amneal Pharmaceuticals Revenue in ADHD Medications Business (2019-2024) & (US$ Million)
Table 50. Amneal Pharmaceuticals Recent Development
Table 51. Eli Lilly and Co. Company Detail
Table 52. Eli Lilly and Co. Business Overview
Table 53. Eli Lilly and Co. ADHD Medications Product
Table 54. Eli Lilly and Co. Revenue in ADHD Medications Business (2019-2024) & (US$ Million)
Table 55. Eli Lilly and Co. Recent Development
Table 56. Johnson and Johnson Services Company Detail
Table 57. Johnson and Johnson Services Business Overview
Table 58. Johnson and Johnson Services ADHD Medications Product
Table 59. Johnson and Johnson Services Revenue in ADHD Medications Business (2019-2024) & (US$ Million)
Table 60. Johnson and Johnson Services Recent Development
Table 61. NEOS Therapeutic Company Detail
Table 62. NEOS Therapeutic Business Overview
Table 63. NEOS Therapeutic ADHD Medications Product
Table 64. NEOS Therapeutic Revenue in ADHD Medications Business (2019-2024) & (US$ Million)
Table 65. NEOS Therapeutic Recent Development
Table 66. Takeda Pharmaceutical Company Detail
Table 67. Takeda Pharmaceutical Business Overview
Table 68. Takeda Pharmaceutical ADHD Medications Product
Table 69. Takeda Pharmaceutical Revenue in ADHD Medications Business (2019-2024) & (US$ Million)
Table 70. Takeda Pharmaceutical Recent Development
Table 71. Pfizer Company Detail
Table 72. Pfizer Business Overview
Table 73. Pfizer ADHD Medications Product
Table 74. Pfizer Revenue in ADHD Medications Business (2019-2024) & (US$ Million)
Table 75. Pfizer Recent Development
Table 76. Lupin Company Detail
Table 77. Lupin Business Overview
Table 78. Lupin ADHD Medications Product
Table 79. Lupin Revenue in ADHD Medications Business (2019-2024) & (US$ Million)
Table 80. Lupin Recent Development
Table 81. Shire Company Detail
Table 82. Shire Business Overview
Table 83. Shire ADHD Medications Product
Table 84. Shire Revenue in ADHD Medications Business (2019-2024) & (US$ Million)
Table 85. Shire Recent Development
Table 86. Mallinckrodt Company Detail
Table 87. Mallinckrodt Business Overview
Table 88. Mallinckrodt ADHD Medications Product
Table 89. Mallinckrodt Revenue in ADHD Medications Business (2019-2024) & (US$ Million)
Table 90. Mallinckrodt Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global ADHD Medications Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global ADHD Medications Market Share by Type: 2023 VS 2030
Figure 3. Stimulant Features
Figure 4. Non-stimulant Features
Figure 5. Global ADHD Medications Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global ADHD Medications Market Share by Application: 2023 VS 2030
Figure 7. Adult Case Studies
Figure 8. Children Case Studies
Figure 9. ADHD Medications Report Years Considered
Figure 10. Global ADHD Medications Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global ADHD Medications Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global ADHD Medications Market Share by Region: 2023 VS 2030
Figure 13. Global ADHD Medications Market Share by Players in 2023
Figure 14. Global Top ADHD Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ADHD Medications as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by ADHD Medications Revenue in 2023
Figure 16. North America ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America ADHD Medications Market Share by Country (2019-2030)
Figure 18. United States ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe ADHD Medications Market Share by Country (2019-2030)
Figure 22. Germany ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific ADHD Medications Market Share by Region (2019-2030)
Figure 30. China ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America ADHD Medications Market Share by Country (2019-2030)
Figure 38. Mexico ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa ADHD Medications Market Share by Country (2019-2030)
Figure 42. Turkey ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Amneal Pharmaceuticals Revenue Growth Rate in ADHD Medications Business (2019-2024)
Figure 45. Eli Lilly and Co. Revenue Growth Rate in ADHD Medications Business (2019-2024)
Figure 46. Johnson and Johnson Services Revenue Growth Rate in ADHD Medications Business (2019-2024)
Figure 47. NEOS Therapeutic Revenue Growth Rate in ADHD Medications Business (2019-2024)
Figure 48. Takeda Pharmaceutical Revenue Growth Rate in ADHD Medications Business (2019-2024)
Figure 49. Pfizer Revenue Growth Rate in ADHD Medications Business (2019-2024)
Figure 50. Lupin Revenue Growth Rate in ADHD Medications Business (2019-2024)
Figure 51. Shire Revenue Growth Rate in ADHD Medications Business (2019-2024)
Figure 52. Mallinckrodt Revenue Growth Rate in ADHD Medications Business (2019-2024)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Table 1. Global ADHD Medications Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Stimulant
Table 3. Key Players of Non-stimulant
Table 4. Global ADHD Medications Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global ADHD Medications Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global ADHD Medications Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global ADHD Medications Market Share by Region (2019-2024)
Table 8. Global ADHD Medications Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global ADHD Medications Market Share by Region (2025-2030)
Table 10. ADHD Medications Market Trends
Table 11. ADHD Medications Market Drivers
Table 12. ADHD Medications Market Challenges
Table 13. ADHD Medications Market Restraints
Table 14. Global ADHD Medications Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global ADHD Medications Market Share by Players (2019-2024)
Table 16. Global Top ADHD Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ADHD Medications as of 2023)
Table 17. Ranking of Global Top ADHD Medications Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by ADHD Medications Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players ADHD Medications Product Solution and Service
Table 21. Date of Enter into ADHD Medications Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global ADHD Medications Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global ADHD Medications Revenue Market Share by Type (2019-2024)
Table 25. Global ADHD Medications Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global ADHD Medications Revenue Market Share by Type (2025-2030)
Table 27. Global ADHD Medications Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global ADHD Medications Revenue Market Share by Application (2019-2024)
Table 29. Global ADHD Medications Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global ADHD Medications Revenue Market Share by Application (2025-2030)
Table 31. North America ADHD Medications Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America ADHD Medications Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America ADHD Medications Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe ADHD Medications Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe ADHD Medications Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe ADHD Medications Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific ADHD Medications Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific ADHD Medications Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific ADHD Medications Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America ADHD Medications Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America ADHD Medications Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America ADHD Medications Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa ADHD Medications Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa ADHD Medications Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa ADHD Medications Market Size by Country (2025-2030) & (US$ Million)
Table 46. Amneal Pharmaceuticals Company Detail
Table 47. Amneal Pharmaceuticals Business Overview
Table 48. Amneal Pharmaceuticals ADHD Medications Product
Table 49. Amneal Pharmaceuticals Revenue in ADHD Medications Business (2019-2024) & (US$ Million)
Table 50. Amneal Pharmaceuticals Recent Development
Table 51. Eli Lilly and Co. Company Detail
Table 52. Eli Lilly and Co. Business Overview
Table 53. Eli Lilly and Co. ADHD Medications Product
Table 54. Eli Lilly and Co. Revenue in ADHD Medications Business (2019-2024) & (US$ Million)
Table 55. Eli Lilly and Co. Recent Development
Table 56. Johnson and Johnson Services Company Detail
Table 57. Johnson and Johnson Services Business Overview
Table 58. Johnson and Johnson Services ADHD Medications Product
Table 59. Johnson and Johnson Services Revenue in ADHD Medications Business (2019-2024) & (US$ Million)
Table 60. Johnson and Johnson Services Recent Development
Table 61. NEOS Therapeutic Company Detail
Table 62. NEOS Therapeutic Business Overview
Table 63. NEOS Therapeutic ADHD Medications Product
Table 64. NEOS Therapeutic Revenue in ADHD Medications Business (2019-2024) & (US$ Million)
Table 65. NEOS Therapeutic Recent Development
Table 66. Takeda Pharmaceutical Company Detail
Table 67. Takeda Pharmaceutical Business Overview
Table 68. Takeda Pharmaceutical ADHD Medications Product
Table 69. Takeda Pharmaceutical Revenue in ADHD Medications Business (2019-2024) & (US$ Million)
Table 70. Takeda Pharmaceutical Recent Development
Table 71. Pfizer Company Detail
Table 72. Pfizer Business Overview
Table 73. Pfizer ADHD Medications Product
Table 74. Pfizer Revenue in ADHD Medications Business (2019-2024) & (US$ Million)
Table 75. Pfizer Recent Development
Table 76. Lupin Company Detail
Table 77. Lupin Business Overview
Table 78. Lupin ADHD Medications Product
Table 79. Lupin Revenue in ADHD Medications Business (2019-2024) & (US$ Million)
Table 80. Lupin Recent Development
Table 81. Shire Company Detail
Table 82. Shire Business Overview
Table 83. Shire ADHD Medications Product
Table 84. Shire Revenue in ADHD Medications Business (2019-2024) & (US$ Million)
Table 85. Shire Recent Development
Table 86. Mallinckrodt Company Detail
Table 87. Mallinckrodt Business Overview
Table 88. Mallinckrodt ADHD Medications Product
Table 89. Mallinckrodt Revenue in ADHD Medications Business (2019-2024) & (US$ Million)
Table 90. Mallinckrodt Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global ADHD Medications Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global ADHD Medications Market Share by Type: 2023 VS 2030
Figure 3. Stimulant Features
Figure 4. Non-stimulant Features
Figure 5. Global ADHD Medications Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global ADHD Medications Market Share by Application: 2023 VS 2030
Figure 7. Adult Case Studies
Figure 8. Children Case Studies
Figure 9. ADHD Medications Report Years Considered
Figure 10. Global ADHD Medications Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global ADHD Medications Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global ADHD Medications Market Share by Region: 2023 VS 2030
Figure 13. Global ADHD Medications Market Share by Players in 2023
Figure 14. Global Top ADHD Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ADHD Medications as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by ADHD Medications Revenue in 2023
Figure 16. North America ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America ADHD Medications Market Share by Country (2019-2030)
Figure 18. United States ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe ADHD Medications Market Share by Country (2019-2030)
Figure 22. Germany ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific ADHD Medications Market Share by Region (2019-2030)
Figure 30. China ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America ADHD Medications Market Share by Country (2019-2030)
Figure 38. Mexico ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa ADHD Medications Market Share by Country (2019-2030)
Figure 42. Turkey ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia ADHD Medications Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Amneal Pharmaceuticals Revenue Growth Rate in ADHD Medications Business (2019-2024)
Figure 45. Eli Lilly and Co. Revenue Growth Rate in ADHD Medications Business (2019-2024)
Figure 46. Johnson and Johnson Services Revenue Growth Rate in ADHD Medications Business (2019-2024)
Figure 47. NEOS Therapeutic Revenue Growth Rate in ADHD Medications Business (2019-2024)
Figure 48. Takeda Pharmaceutical Revenue Growth Rate in ADHD Medications Business (2019-2024)
Figure 49. Pfizer Revenue Growth Rate in ADHD Medications Business (2019-2024)
Figure 50. Lupin Revenue Growth Rate in ADHD Medications Business (2019-2024)
Figure 51. Shire Revenue Growth Rate in ADHD Medications Business (2019-2024)
Figure 52. Mallinckrodt Revenue Growth Rate in ADHD Medications Business (2019-2024)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232